Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide have been gaining considerable attention for their ability to help people manage and lose weight. OzempicĀ® is the brand name for Novo Nordiskās drug semaglutide, while MounjaroĀ® is the brand name for Eli Lillyās drug tirzepatide. Tirzepatide also works on another receptor in the body, gastric inhibitory polypetide …

